Syncom Formulations (India) Limited

Syncom Formulations (India) Limited

Share · INE312C01025 (XNSE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Syncom Formulations (India) Limited
No Price
Closing Price XNSE 29.04.2026: 13,79 INR
29.04.2026 09:59
Current Prices from Syncom Formulations (India) Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
SYNCOMF.NS
INR
29.04.2026 09:59
13,79 INR
-0,12 INR
-0,86 %
XBOM: MSE
MSE
SYNCOMF.BO
INR
29.04.2026 09:59
13,77 INR
-0,14 INR
-1,01 %
Share Float & Liquidity
Free Float 49,16 %
Shares Float 462,12 M
Shares Outstanding 940 M
Company Profile for Syncom Formulations (India) Limited Share
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.

Company Data

Name Syncom Formulations (India) Limited
Company Syncom Formulations (India) Limited
Website https://www.syncomformulations.com
Primary Exchange XNSE NSE
ISIN INE312C01025
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Ankit Kedarmal Bankda
Market Capitalization 13 Mrd.
Country India
Currency INR
Employees 1,0 T
Address 207, Saket Nagar, 452018 Indore
IPO Date 2022-11-18
Dividends from 'Syncom Formulations (India) Limited'
Ex-Date Dividend per Share
09.09.2022 0,03 INR
21.09.2017 0,02 INR
22.09.2016 0,02 INR
16.09.2015 0,02 INR
18.09.2014 0,02 INR
10.07.2013 21,00 INR
20.09.2012 21,00 INR
22.09.2011 17,50 INR
23.09.2010 17,50 INR
24.09.2009 17,50 INR

Stock Splits

Date Split
19.08.2013 35:1

Ticker Symbols

Name Symbol
MSE SYNCOMF.BO
NSE SYNCOMF.NS
More Shares
Investors who hold Syncom Formulations (India) Limited also have the following shares in their portfolio:
Norddeutsche Landesbank -GZ- EO-IHS 23(27)
Norddeutsche Landesbank -GZ- EO-IHS 23(27) Unbekannt
Trusco Nakayama Corporation
Trusco Nakayama Corporation Share